Regulatory
What regulation could change about the listed live economy
This page reads regulation as an exposure question. The legal record itself — filings, parties, dates, remedies sought — lives in the antitrust tracker, and is not restated here.
- Status
- Framework — exposure mapped, no quantified impact published
- Method version
- 1.0
- Reviewed
- 2026-08-22
No estimate of revenue at risk, remedy probability or valuation impact appears on this page. Those are forecasts, and Live Index does not publish forecasts as data.
The primary record
Live Index maintains a continuously updated record of the 2024 to 2026 Live Nation and Ticketmaster antitrust litigation, built from docket entries and primary filings. It is the authoritative account on this site of what has been alleged, by whom, and what relief is sought.
This page does not duplicate it. Where a milestone matters to how the listed sector is structured, the milestone is cited to the tracker rather than restated, so there is one place where a date can be wrong and one place where it gets corrected.
Channels of exposure
Each channel below describes a mechanism by which a regulatory outcome would change a company’s revenue structure. The mechanism is the claim; the magnitude is not, and is left blank until it can be measured against filed figures.
| Channel | Mechanism | Index field affected |
|---|---|---|
| Structural relief | Separation of ticketing from promotion or venue operation would split one revenue base into entities with different live exposure. | Segment assignment, live revenue exposure |
| Conduct remedies | Limits on exclusive ticketing terms or venue exclusivity change the durability of contracted volume rather than its level in a single period. | Exposure durability note |
| Fee disclosure rules | All-in pricing requirements move the displayed price without necessarily moving the collected total, so a headline price change is not a revenue change. | Take rate interpretation |
| Resale regulation | Restrictions on speculative listings and transfer terms shift where a secondary margin is captured between primary platform and reseller. | Segment boundary, ticketing |
How to read a remedy as an exposure
A remedy that changes who owns an asset changes the index by moving revenue between records. A remedy that changes how a price is displayed may change nothing measurable at all. Treating those two as the same event is the most common error in reading regulatory news against a sector.
The methodology therefore treats a corporate action arising from relief as an ordinary corporate action: the affected record is restated at the effective date, the prior figure is retained, and the change is recorded rather than overwritten.